Horizons Optical continues on a path of upward growth

2022 has ended and it is time to take stock of the results. For Horizons Optical, the Spanish company focused on innovation and technology for the optical industry, this has been a year full of news that confirms the company’s positive growth: the opening of a subsidiary in the USA, opening of a new headquarters in Barcelona and a new commercial office in Colombia.

Horizons’ growth path reached a 60% increase in turnover by the end of 2022 compared to the previous year, a rising value projected to increase in 2023. According to the data provided by the company, Horizons Optical expects an increase of 93% in the first quarter of 2023.

Much of the success is due to the positive reception of mimesys^®, the optical solution for presbyopes that is a pioneer in using virtual reality to analyze people’s gaze dynamics and offer personalized progressive lenses like never before. According to the CEO of Horizons, Santiago Soler, the Spanish company has a leadership position in the implementation of immersive technology in optical retail thanks to rapid market penetration that has allowed it to reach more than 1,000 opticians and 36,000 patients in Europe in nine months. In 2023, Horizons will continue to promote the innovation of disruptive solutions with the aim of improving not only the quality of the lenses but also the progressive glasses purchasing experience.

Another one of the factors has been the increase in its core business of selling freeform designs. Horizons has for the first time reached 8 million freeform lenses produced with Horizons technology. This volume is achieved through the more than 130 ophthalmic laboratories that use Horizons designs to manufacture their ophthalmic lenses throughout the world.

Last but not least, the Horizons team has been strengthened through the hiring of talent, i.e., growing the workforce by 30%, and incorporating scientists from various fields to continue generating the innovation that has led Horizons to owning nine families of patents in Europe and the USA.